0
0
Home > Pharmaceuticals >  CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China

GlobalData, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – China”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in China. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The population of China in 2014 was approximately 1.37 billion, having grown at a Compound Annual Growth Rate (CAGR) of 0.5% from 2008. The country’s increasingly elderly population and a corresponding increase in the incidence of chronic diseases will help to boost the growth of the pharmaceutical industry, which was estimated to be worth $106.5 billion in 2008 and is projected to reach $1,637.3 billion by 2020, at a CAGR of 25.6%. Approximately 95% of China’s population has healthcare coverage. Improvements in drug safety and quality; a shorter drug registration timeline; the elimination of price caps by the government; a more transparent system for the approval of drugs and medical instruments; and an IPR regime are driving innovation in the pharmaceutical sector. These changes encourage foreign Multinational Companies (MNC) to invest in China. The Chinese medical device market is the second largest in Asia, valued at $27.7 billion in 2014 and projected to grow at a CAGR of 10.6% to an estimated $50.8 billion in 2020. These growth trends can be primarily attributed to the following causes:

Sedentary lifestyles leading to a high chronic disease burden.

The accessibility of healthcare professionals in the remote areas of the county.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in China, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market: GlaxoSmithKline, Pfizer, AstraZeneca, Harbin Pharmaceutical Group, Tianjin Tasly Pharmaceutical Group, Jiangsu Hengru Medicine, Qilu Pharmaceutical and CSPC Pharmaceutical and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, GE Healthcare, Philips, Medtronic and F. Hoffman La Roche

Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving China’s healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect China’s healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships

Identify, understand, and capitalize on the opportunities and challenges in China’s healthcare market

Table of Contents

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 GlobalData Report Guidance

3 Overview of Pharmaceutical and Medical Device Markets

3.1 Pharmaceutical Market

3.1.1 Market Overview

3.1.2 Pharmaceutical Exports and Imports

3.1.3 Supply Channels

3.1.4 Market Segments

3.1.5 Overview of Top Five Disease Areas

3.1.6 Major Players

3.2 Medical Device Market

3.2.1 Market Overview

3.2.2 Overview of Top Five Segments

3.2.3 Diagnostic Market

3.2.4 Major Players

3.3 Market Drivers and Barriers

3.3.1 Drivers

3.3.2 Barriers

4 Market Access

4.1 Overview of the Healthcare System

4.2 Reimbursement and Payer Landscape

4.2.1 Reimbursement Process

4.2.2 Overview of Insurance Providers

4.2.3 Patient Share in Healthcare Spending

4.2.4 Prescription Drug Price Trend

4.2.5 Pricing Policies

4.3 Regulatory Landscape

4.3.1 Overview of Regulatory Agencies

4.3.2 Market Authorization Procedure for Pharmaceutical Products

4.3.3 Market Authorization Procedure for Medical Devices

4.3.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing

4.3.5 Licensing Process for Pharmaceutical Exports and Imports

4.3.6 Intellectual Property Rights

4.3.7 Clinical Trial Regulations

4.3.8 Pharmaceutical Advertising Regulations

4.3.9 Pharmacy Regulations

4.3.10 Labeling and Packaging Regulations

5 Country Analysis

5.1 Political Environment

5.1.1 Political Structure

5.1.2 Analysis of the Current Political Environment

5.1.3 Healthcare Policy Initiatives

5.2 Economic Landscape

5.3 Economic Indicators

5.3.1 Gross Domestic Product

5.3.2 Gross National Income

5.3.3 Inflation

5.3.4 Currency Exchange Rate

5.3.5 Foreign Direct Investment

5.3.6 Foreign Exchange Reserves

5.3.7 Trade Balance

5.3.8 General Government Structural Balance

5.3.9 General Government Gross Debt

5.3.10 Major Industries

5.4 Demographics

5.4.1 Population

5.4.2 Education and Literacy Rate

5.4.3 Employment

5.4.4 Disease Burden

5.5 Healthcare Infrastructure

5.5.1 Hospitals

5.5.2 Healthcare Facilities

5.5.3 Healthcare Parameters

5.5.4 Environmental Health

5.5.5 Healthcare Personnel

5.6 Healthcare Expenditure

5.6.1 Overview

5.6.2 Public and Private Sector Share

5.7 Trade Associations

5.7.1 China Chamber of Commerce for Import and Export of Medicines and Health Products

5.7.2 China Healthcare Association

5.7.3 Shanghai Medical Instrument Trade Association

5.7.4 Chinese Hospital Association

5.7.5 China Pharmaceutical Industry Association

5.8 Trade Fairs

6 Opportunities and Challenges

6.1 Opportunities

6.2 Challenges

7 Appendix

7.1 Abbreviations

7.2 Bibliography

7.3 Research Methodology

7.3.1 Coverage

7.3.2 Secondary Research

7.3.3 Forecasts

7.3.4 Expert Panel

7.4 Disclaimer

List of Tables

Table 1: Pharmaceutical Market, China, Revenue ($bn), 2008–2014

Table 2: Pharmaceutical Market, China, Revenue Forecast ($bn), 2015–2020

Table 3: Pharmaceutical Market, China, Exports and Imports ($bn), 2008–2014

Table 4: GlaxoSmithKline, Global, Major Products, Revenue ($bn), 2014

Table 5: Late-stage Pipeline, GlaxoSmithKline, 2015

Table 6: Pharmaceutical Market, Pfizer, Global, Major Products, 2014

Table 7: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2015

Table 8: Major Products, AstraZeneca, Global, Revenue ($bn), 2014

Table 9: Late-stage Pipeline, AstraZeneca, 2015

Table 10: Major Products, Harbin Pharmaceuticals Group, 2015

Table 11: Major Products, Tasly, 2015

Table 12: Major Products, Jiangsu Hengrui Medicine, 2015

Table 13: Major Products, Qilu Pharmaceutical, Active Pharmaceutical Ingredients, 2015

Table 14: Major Products, CSPC Pharmaceutical

Table 15: Medical Device Market, China, Revenue ($bn), 2008–2014

Table 16: Medical Device Market, China, Revenue Forecast ($bn), 2014–2020

Table 17: Medical Device Market, China, Revenue by Segment, 2014

Table 18: Medical Device Market, China, Ophthalmic Devices Market, Revenue ($bn), 2008–2014

Table 19: Medical Device Market, China, Ophthalmic Devices Market, Market Share for Major Players, 2012

Table 20: Medical Device Market, China, Diagnostic Imaging Market, Revenue ($bn), 2008–2014

Table 21: Medical Device Market, China, Diagnostic Imaging Market, Market Share for Major Players, 2012

Table 22: Medical Device Market, China, In Vitro Diagnostic Market, Revenue ($bn), 2008–2014

Table 23: Medical Device Market, China, In Vitro Diagnostic Market, Market Share for Major Players, 2012

Table 24: Medical Device Market, China, Cardiovascular Device Market, Revenue ($bn), 2008–2014

Table 25: Medical Device Market, China, Cardiovascular Device Market, Market Share for Major Players, 2012

Table 26: Medical Device Market, China, Orthopedic Device Market, Revenue ($bn), 2008–2014

Table 27: Medical Device Market, China, Orthopedic Device Market, Market Share for Major Players, 2012

Table 28: Medical Device Market, China, Diagnostic Market, Revenue ($bn), 2008–2014

Table 29: Medical Device Market, China, Diagnostic Market, Revenue Forecast ($bn), 2015–2020

Table 30: Medical Device Market, China, Major Medical Device Companies, Revenue, 2012

Table 31: Medical Device Market, Major Products, Medtronic, 2014

Table 32: Healthcare Spending, China, Out-of-Pocket Expenditure (% of Total Healthcare Expenditure), 2008–2014

Table 33: Market Access, China, Healthcare Consumer Price Index, 2008–2014

Table 34: Economic Indicators, China, GDP per Capita ($), 2008–2014

Table 35: Economic Indicators, China, GDP per Capita Forecast ($), 2015–2020

Table 36: Economic Indicators, China, GDP Growth (%), 2008–2014

Table 37: Economic Indicators, China, GDP Annual Growth Forecast (%), 2015–2020

Table 38: Economic Indicators, China, Gross National Income per Capita ($), 2008–2014

Table 39: Economic Indicators, China, Average Consumer Price Index, 2008–2014

Table 40: Economic Indicators, China, Average Consumer Price Index Forecast, 2014–2020

Table 41: Economic Indicators, China, Average Consumer Price Change (%), 2008–2014

Table 42: Economic Indicators, China, Currency Exchange Rate (CNY/$), 2008–2014

Table 43: Economic Indicators, China, Foreign Direct Investment ($bn), 2008–2014

Table 44: Economic Indicators, China, Foreign Exchange Reserves ($tn), 2008–2014

Table 45: Economic Indicators, China, Trade Balance ($bn), 2008–2014

Table 46: Economic Indicators, China, Imports of Goods and Services ($tn), 2008–2014

Table 47: Economic Indicators, China, Exports of Goods and Services ($tn), 2008–2014

Table 48: Economic Indicators, China, Government Structural Balance ($bn), 2008–2014

Table 49: Economic Indicators, China, General Government Gross Debt ($tn), 2008–2014

Table 50: Economic Indicators, China, Major Industries, GDP by production ($tn), 2013

Table 51: Demographics, China, Population (billion), 2008–2014

Table 52: Demographics, China, Population Forecast (billion), 2015–2020

Table 53: Demographics, China, Population, Urban and Rural Population (%), 2008–2013

Table 54: Demographics, China Population Distribution by Age Group (%), 2008–2014

Table 55: Demographics, China, Population Distribution by Age Group Forecast (%), 2014–2020

Table 56: Demographics, China, Births (per 1,000 Population), 2008–2014

Table 57: Demographics, China, Mortality (per 1,000 Population), 2008–2014

Table 58: Demographics, China, Major Causes of Mortality (per 1,000 population), 2011

Table 59: Demographics, China, Children ≤5 Years, Mortality Rate (per 1,000 Live Births), 2008–2014

Table 60: Demographics, China, Immunization (%), 2008–2014

Table 61: Demographics, China, Major Causes of Male Mortality (%), 2011

Table 62: Demographics, China, Major Causes of Female Mortality (%), 2011

Table 63: Demographics, China, Gender Ratio (Males per 100 Females), 2008–2014

Table 64: Demographics, China, Life Expectancy (Years), 2008–2014

Table 65: Demographics, China, Student Enrollment by Level of Education (million), 2014

Table 66: Demographics, China, Unemployment Rate in Urban Areas (%), 2008–2014

Table 67: Demographics, China, Major Diseases, City Hospital In-Patients (%), 2011

Table 68: Demographics, China, Major Diseases, Share of County Hospital In-Patients (%), 2011

Table 69: Demographics, China, Major Diseases, DALY (per 100,000 Population), 2009

Table 70: Healthcare Infrastructure, China, Hospitals, 2008–2014

Table 71: Healthcare Infrastructure, China, Hospitals by Bed Size (%), 2011

Table 72: Healthcare Infrastructure, China, Hospitals Beds (million), 2008–2014

Table 73: Healthcare Infrastructure, China, Hospital Beds (per 1,000 Population), 2008–2014

Table 74: Healthcare Infrastructure, China, Doctors (per 1,000 Population), 2008–2014

Table 75: Healthcare Infrastructure, China, CO2 Emissions (Metric Tons per Capita), 2008–2014

Table 76: Healthcare Infrastructure, China, PM10 Emissions (µg/m3), 2008–2014

Table 77: Healthcare Infrastructure, China, Nurses (per 1,000 Population), 2008–2014

Table 78: Healthcare Expenditure, China, Healthcare Expenditure (% of GDP), 2008–2014

Table 79: Healthcare Expenditure, China, Public–Private Share of Healthcare Expenditure (%), 2008–2014

Table 80: Trade Fairs, China, Major Healthcare Trade Fairs, 2015

List of Figures

Figure 1: Pharmaceutical Market, China, Revenue ($bn), 2008–2014

Figure 2: Pharmaceutical Market, China, Revenue Forecast ($bn), 2015–2020

Figure 3: Pharmaceutical Market, China, Exports and Imports ($bn), 2008–2014

Figure 4: Pharmaceutical Distribution Channels, China, 2015

Figure 5: Medical Device Market, China, Revenue ($bn), 2008–2014

Figure 6: Medical Device Market, China, Revenue Forecast ($bn), 2014–2020

Figure 7: Medical Device Market, China, Revenue by Segment ($bn), 2014

Figure 8: Medical Device Market, China, Ophthalmic Devices Market, Revenue ($bn), 2008–2014

Figure 9: Medical Device Market, China, Ophthalmic Devices Market, Market Share for Major Players (%), 2012

Figure 10: Medical Device Market, China, Diagnostic Imaging Market, Revenue ($bn), 2008–2014

Figure 11: Medical Device Market, China, Diagnostic Imaging Market, Market Share for Major Players (%), 2012

Figure 12: Medical Device Market, China, In Vitro Diagnostic Market, Revenue ($bn), 2008–2014

Figure 13: Medical Device Market, China, In Vitro Diagnostic Market, Market Share for Major Players (%), 2012

Figure 14: Medical Device Market, China, Cardiovascular Device Market, Revenue ($bn), 2008–2014

Figure 15: Medical Device Market, China, Cardiovascular Device Market, Market Share for Major Players (%), 2012

Figure 16: Medical Device Market, China, Orthopedic Device Market, Revenue ($bn), 2008–2014

Figure 17: Medical Device Market, China, Orthopedic Device Market, Market Share for Major Players (%), 2012

Figure 18: Medical Device Market, China, Diagnostic Market, Revenue ($bn), 2008–2014

Figure 19: Medical Device Market, China, Diagnostic Market, Revenue Forecast ($bn), 2015–2020

Figure 20: Medical Device Market, China, Major Medical Device Companies, Revenue ($m), 2012

Figure 21: Healthcare Market, China, Drivers and Barriers, 2014

Figure 22: Healthcare System, China, Key Influences in Reimbursement Procedure, 2013

Figure 23: Healthcare Spending, China, Out-of-Pocket Expenditure (% of Total Healthcare Expenditure), 2008–2014

Figure 24: Market Access, China, Healthcare Price Index, 2008–2014

Figure 25: Market Access, SFDA Structure, 2013

Figure 26: Healthcare System, China, New Drug Approval Process, 2013

Figure 27: Healthcare System, China, New Medical Device Approval Process, 2013

Figure 28: Economic Indicators, China, GDP per Capita ($), 2008–2014

Figure 29: Economic Indicators, China, GDP per Capita Forecast ($), 2015–2020

Figure 30: Economic Indicators, China, GDP Growth (%), 2008–2014

Figure 31: Economic Indicators, China, GDP Growth Forecast (%), 2015–2020

Figure 32: Economic Indicators, China Gross National Income per Capita ($), 2008–2014

Figure 33: Economic Indicators, China, Average Consumer Price Index, 2008–2014

Figure 34: Economic Indicators, China, Average Consumer Price Index Forecast, 2014–2020

Figure 35: Economic Indicators, China, Average Consumer Price Change (%), 2008–2014

Figure 36: Economic Indicators, China, Currency Exchange Rate (CNY/$), 2008–2014

Figure 37: Economic Indicators, China, Foreign Direct Investment ($bn), 2008–2014

Figure 38: Economic Indicators, China, Foreign Exchange Reserves ($tn), 2008–2014

Figure 39: Economic Indicators, China, Trade Balance ($bn), 2008–2014

Figure 40: Economic Indicators, China, Imports ($tn), 2008–2014

Figure 41: Economic Indicators, China, Exports ($tn), 2008–2014

Figure 42: Economic Indicators, China, Government Structural Balance ($bn), 2008–2014

Figure 43: Economic Indicators, China, General Government Gross Debt ($tn), 2008–2014

Figure 44: Economic Indicators, China, Major Industries, GDP by Production ($tn), 2013

Figure 45: Demographics, China, Population (billion), 2008–2014

Figure 46: Demographics, China, Population Forecast (bn), 2015–2020

Figure 47: Demographics, China, Population, Urban and Rural Population (%), 2008–2014

Figure 48: Demographics, China, Population Distribution by Age Group (%), 2008–2014

Figure 49: Demographics, China, Population Distribution by Age Group Forecast (%), 2015–2020

Figure 50: Demographics, China, Birth Rate (per 1,000 Population), 2008–2014

Figure 51: Demographics, China, Mortality (per 1,000 Population), 2008–2014

Figure 52: Demographics, China, Major Causes of Mortality (per 1,000 population), 2011

Figure 53: Demographics, China, Children ≤5 Years, Mortality Rate (per 1,000 Live Births), 2008–2014

Figure 54: Demographics, China, Immunization (%), 2008–2014

Figure 55: Demographics, China, Main Causes of Male Mortality (%), 2011

Figure 56: Demographics, China, Major Causes of Female Mortality (%), 2011

Figure 57: Demographics, China, Gender Ratio (Males per 100 Females), 2008–2014

Figure 58: Demographics, China, Life Expectancy (Years), 2008–2014

Figure 59: Demographics, China, Student Enrollment by Level of Education (million), 2014

Figure 60: Demographics, China, Unemployment Rate in Urban Areas (%), 2008–2014

Figure 61: Demographics, China, Major Diseases, City Hospital In-Patients (%), 2011

Figure 62: Demographics, China, Major Diseases, Share of County Hospital In-Patients (%), 2011

Figure 63: Demographics, China, Major Diseases, DALY (per 100,000 Population), 2009

Figure 64: Healthcare Infrastructure, China, Hospitals, 2008–2014

Figure 65: Healthcare Infrastructure, China, Hospitals by Bed Number (%), 2011

Figure 66: Healthcare Infrastructure, China, Hospitals Beds (million), 2008–2014

Figure 67: Healthcare Infrastructure, China, Hospital Beds (per 1,000 Population), 2008–2014

Figure 68: Healthcare Infrastructure, China, Doctors (per 1,000 Population), 2008–2014

Figure 69: Healthcare Infrastructure, China, CO2 Emissions (Metric Tons per Capita), 2008–2014

Figure 70: Healthcare Infrastructure, China, PM10 Emissions (µg/m3), 2008–2014

Figure 71: Healthcare Infrastructure, China, Nurses (per 1,000 Population), 2008–2014

Figure 72: Healthcare Expenditure, China, Healthcare Expenditure (% of GDP), 2008–2014

Figure 73: Healthcare Expenditure, China, Public–Private Share of Healthcare Expenditure (%), 2008–2014

Figure 74: Healthcare Market, China, Opportunities and Challenges, 2014

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports